Cytokinetics (CYTK) had the highest return between December 13, 2023 and December 28, 2023 by a mid-cap US stock, returning 137.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
Cytokinetics (CYTK) | 12/13/2023 - 12/28/2023 | 137.08% |
Bitdeer Technologies Group Class A Ordinary Shares (BTDR) | 12/13/2023 - 12/28/2023 | 120.33% |
Compania de Minas Buenaventura SAA ADR (BVN) | 12/13/2023 - 12/28/2023 | 66.27% |
Sunrun (RUN) | 12/13/2023 - 12/28/2023 | 64% |
CleanSpark (CLSK) | 12/13/2023 - 12/28/2023 | 49.32% |
ACADIA Pharmaceuticals (ACAD) | 12/13/2023 - 12/28/2023 | 45.98% |
Compass (COMP) | 12/13/2023 - 12/28/2023 | 44.57% |
Alcoa (AA) | 12/13/2023 - 12/28/2023 | 43.72% |
QXO (QXO) | 12/13/2023 - 12/28/2023 | 41.74% |
Apogee Therapeutics, Inc Common Stock (APGE) | 12/13/2023 - 12/28/2023 | 40.74% |
Enphase Energy (ENPH) | 12/13/2023 - 12/28/2023 | 40.7% |
P3 Health Partners (PIII) | 12/13/2023 - 12/28/2023 | 39.09% |
Verona Pharma PLC ADR (VRNA) | 12/13/2023 - 12/28/2023 | 36.49% |
VinFast Auto Ltd Ordinary Shares (VFS) | 12/13/2023 - 12/28/2023 | 35% |
United States Steel (X) | 12/13/2023 - 12/28/2023 | 33.42% |
Nio Inc Class A ADR (NIO) | 12/13/2023 - 12/28/2023 | 31.52% |
Avidity Biosciences (RNA) | 12/13/2023 - 12/28/2023 | 31.41% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 12/13/2023 - 12/28/2023 | 31.33% |
MP Materials (MP) | 12/13/2023 - 12/28/2023 | 31.3% |
Globalstar, Inc Common Stock (GSAT) | 12/13/2023 - 12/28/2023 | 31.25% |
EchoStar (SATS) | 12/13/2023 - 12/28/2023 | 30.84% |
Moderna (MRNA) | 12/13/2023 - 12/28/2023 | 29.99% |
Catalyst Pharmaceuticals (CPRX) | 12/13/2023 - 12/28/2023 | 29.32% |
Dream Finders Homes (DFH) | 12/13/2023 - 12/28/2023 | 28.48% |
Glaukos (GKOS) | 12/13/2023 - 12/28/2023 | 28.38% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
